Xopenex Inhalation Solution - Ownership and Business Overview

Medical ProductsCompany

Xopenex Inhalation Solution Ownership

Who owns Xopenex Inhalation Solution?

Xopenex Inhalation Solution is owned by Akorn. It was acquired on September 30, 2014.

Xopenex Inhalation Solution Business Overview

Where is Xopenex Inhalation Solution headquartered?

Xopenex Inhalation Solution is headquartered in United States.

What sector is Xopenex Inhalation Solution in?

Xopenex Inhalation Solution is a medical products company.

Medical Products M&A Summary in 2014

Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2014. The largest medical products acquisition in 2014 was Covidien - which was acquired by Medtronic for $42.9B.

Join Mergr to view all 216 acquisitions of medical products companies in 2014, including 24 acquisitions by private equity firms, and 192 by strategics.

Xopenex Inhalation Solution


United States,

Xopenex (levalbuterol HCl) Inhalation Solution is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease.


 Subscribe to unlock this and 201,688
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Xopenex Inhalation Solution

Medical Products Companies , United States Companies